Stock EFTR EFFECTOR THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart eFFECTOR Therapeutics, Inc.

Equities

EFTR

US28202V2079

Real-time Estimate Cboe BZX
Other stock markets
 12:02:08 2024-06-03 pm EDT 		5-day change 1st Jan Change
1.55 USD -3.13% Intraday chart for eFFECTOR Therapeutics, Inc. -11.43% -86.74%
May. 20 EFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer CI
May. 09 EFFECTOR Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
EFFECTOR THERAPEUTICS, INC.
Bio Therapeutic Drugs
-3.12%-11.43%-86.74%-93.86% - 7.53M
Bearish
Bearish
Bearish
  1. Stock Market
  2. Equities
  3. EFTR Stock
  4. Charts eFFECTOR Therapeutics, Inc.
  5. Relative Strength Chart